Testing blood levels after carbon monoxide poisoning treatment
Part of Blood & lymphatic, Injuries & trauma clinical trials.
This trial studies certain tiny particles in the blood in adults with acute carbon monoxide poisoning. It may help researchers understand what happens in the body and how well hyperbaric oxygen treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have had recent (acute) carbon monoxide poisoning
- Be planned for treatment with hyperbaric oxygen
- Agree to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study takes and stores blood (and DNA) from people who were sick from carbon monoxide exposure. It’s meant to help researchers better understand the condition and what happens in the body after exposure.
This trial studies nerve and brain problems that can happen after acute carbon monoxide poisoning. It looks at people who arrive soon after poisoning to better understand what happens and how to help.
This trial looks at how carbon monoxide poisoning affects the heart in patients who received hyperbaric oxygen therapy. It aims to understand the heart risks after treatment.
This study looks at people who have been sickened by carbon monoxide (CO) from an accident or exposure. It aims to better understand what happens over time, which could help improve care and outcomes in the future.
This trial tests whether adding a steroid medication to standard hyperbaric oxygen therapy improves recovery for adults hospitalized with carbon monoxide poisoning.
This trial tests if combining two common medicines, dexamethasone and N-acetylcysteine, can help prevent long-term brain problems in people who have been poisoned by carbon monoxide.
Hear when a new Carbon Monoxide Poisoning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.